Medicine
Voriconazole 50 mg tablet
Voriconazole 50 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Voriconazole
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets, 3 blister pack and 27 more
- Manufacturers
- Viona PharmaceuticalsIndiaZydus LifesciencesIndiaAurobindo PharmaIndiaAjanta PharmaIndiaLupinIndiaSandozSolco HealthcareAmerican Health PackagingMajor PharmaceuticalsMylan Institutional
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J02AC03 Voriconazole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 February 2011
- Identifiers
- RxCUI 349434, 349435DailyMed set ID 4fe672ff-2cef-4f88-ab85-5a4b586da20d, 49dcf3ae-6d6b-46fe-a88e-ec65f2de332e, b38165a5-d8d4-4579-a49a-fbe92e764089 +10NDC 65862-891, 0904-6596, 16714-198 +10Application ANDA206837, ANDA206747, ANDA206654 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 27241-062-03 | Ajanta PharmaIndia | 31 May 2016 |
| 100 tablet, film coated in 1 bottle | 65862-891-01 | Aurobindo PharmaIndia | 22 January 2016 |
| 3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-891-03 | Aurobindo PharmaIndia | 22 January 2016 |
| 500 tablet, film coated in 1 bottle | 65862-891-05 | Aurobindo PharmaIndia | 22 January 2016 |
| 30 tablet, film coated in 1 bottle | 65862-891-30 | Aurobindo PharmaIndia | 22 January 2016 |
| 30 tablet, film coated in 1 bottle | 43386-088-03 | LupinIndia | 24 May 2016 |
| 100 tablet, film coated in 1 bottle | 72578-062-01 | Viona PharmaceuticalsIndia | 16 April 2019 |
| 500 tablet, film coated in 1 bottle | 72578-062-05 | Viona PharmaceuticalsIndia | 16 April 2019 |
| 30 tablet, film coated in 1 bottle | 72578-062-06 | Viona PharmaceuticalsIndia | 16 April 2019 |
| 1000 tablet, film coated in 1 bottle | 72578-062-10 | Viona PharmaceuticalsIndia | 16 April 2019 |
| 90 tablet, film coated in 1 bottle | 72578-062-16 | Viona PharmaceuticalsIndia | 16 April 2019 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 72578-062-77 | Viona PharmaceuticalsIndia | 16 April 2019 |
| 100 tablet, film coated in 1 bottle | 65841-830-01 | Zydus LifesciencesIndia | 25 May 2016 |
| 500 tablet, film coated in 1 bottle | 65841-830-05 | Zydus LifesciencesIndia | 25 May 2016 |
| 30 tablet, film coated in 1 bottle | 65841-830-06 | Zydus LifesciencesIndia | 25 May 2016 |
| 1000 tablet, film coated in 1 bottle | 65841-830-10 | Zydus LifesciencesIndia | 25 May 2016 |
| 90 tablet, film coated in 1 bottle | 65841-830-16 | Zydus LifesciencesIndia | 25 May 2016 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65841-830-77 | Zydus LifesciencesIndia | 25 May 2016 |
| 30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 51079-164-03 | Mylan Institutional | 8 August 2011 |
| 30 tablet, film coated in 1 bottle, plastic | 0378-1626-93 | Mylan Pharmaceuticals | 15 February 2011 |
| 500 tablet, film coated in 1 bottle | 0781-5667-05 | Sandoz | 12 December 2011 |
| 1000 tablet, film coated in 1 bottle | 0781-5667-10 | Sandoz | 12 December 2011 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 0781-5667-13 | Sandoz | 12 December 2011 |
| 30 tablet, film coated in 1 bottle | 0781-5667-31 | Sandoz | 12 December 2011 |
| 30 tablet, coated in 1 bottle | 43547-377-03 | Solco Healthcare | 28 October 2016 |
| 500 tablet, coated in 1 bottle | 43547-377-50 | Solco Healthcare | 28 October 2016 |
| 30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 60687-968-21 | American Health Packaging | 27 August 2026 |
| 30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0904-6596-04 | Major Pharmaceuticals | 25 May 2016 |
| 30 tablet, film coated in 1 bottle | 16714-198-01 | NorthStar Rx | 22 January 2016 |
| 30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 48433-146-03 | Safecor Health | 6 April 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Voriconazole
Clinical summary
Voriconazole is an azole antifungal indicated for the treatment of adults and pediatric patients 2 years of age and older with invasive aspergillosis, among other approved uses. MedsAcross supplies Voriconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VoriconazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VFEND prescribing information (Roerig) · U.S. National Library of Medicine, DailyMed
- Vfend: European public assessment report (EPAR) · European Medicines Agency
- Voriconazole Accord: European public assessment report (EPAR) · European Medicines Agency
Need Voriconazole 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.